To maintain profits in the face of rising development costs and slow drug pipelines, big pharmaceutical firms are trying to cut back. Heidi Ledford examines how GlaxoSmithKline has tried to adapt.
This is a preview of subscription content, log in via an institution to check access.
Related links
Related links
Related links in Nature Research
Related external links
Rights and permissions
About this article
Cite this article
Ledford, H. When there's no room to grow. Nature 454, 144–145 (2008). https://doi.org/10.1038/454144a
Published:
Issue Date:
DOI: https://doi.org/10.1038/454144a
- Springer Nature Limited
This article is cited by
-
Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery
Nature Reviews Drug Discovery (2009)